EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
news

Merck’s Leader in Oral PCSK9 Inhibitor Race Reduces Cholesterol in Pair of Phase 3 Trials

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma unveiled a pair of phase 3 wins for enlici...
Continue Reading →
news

Navigating Clinical Trials: A Guide for Patients Seeking Experimental Treatments

For many patients grappling with serious health conditions like ALS (Amyotrophic Lateral Sclerosis), the search for effective treatments can feel like an uphill batt...
Continue Reading →
news

EU: Trials Should Include Pregnant Subjects where Possible

New guidance from the EMA has introduced a shift in thinking at the regulator on the inclusion of pregnant and breastfeeding women in clinical trials. The new doc...
Continue Reading →
news

New Gold Standard Guidelines for Psychedelic Trials

A new set of guidelines for the use of psychedelics in clinical trials including factors such as music, lighting, and cultural safety aims to become the "gold standa...
Continue Reading →
news

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

START's Site Network Solidifies its Global Leadership in Urological Cancer Trials  The START Center for Cancer Research (“START”), a global leader in early-phase ...
Continue Reading →
news

Clinical Trial Shows Immunotherapy Drug Pembrolizumab Improves Outcomes for Patients with Soft Tissue Sarcoma

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free s...
Continue Reading →
news

Scientists Use AI to Mimic Cancer Patient Trials

Researchers who aim to improve cancer treatment by using artificial intelligence to simulate clinical trials have been given £5.9m in funding by a charity. Th...
Continue Reading →
news

Emmes Awarded Multi-task, IDIQ Contract With $50M Ceiling, to Support NIDA’s Clinical Trials Network

Emmes, part of Emmes Group, announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials Emmes, part ...
Continue Reading →
news

Almac Appoints Global Energy Manager as part of  ongoing commitment to net zero strategy  

The Almac Group has announced the appointment of Ramees Raja as Global Energy Manager. This is a new role that will drive actions to support Almac’s commitment to...
Continue Reading →
news

Tower continues innovation streak with new product launch at CPHI Barcelona

Temperature-controlled container specialist, Tower Cold Chain will be exhibiting its latest concept and products at the world’s largest pharmaceutical event, CPHI. ...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18